0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
17 Ansichten3 Seiten
The global healthcare industry is the most complex, chaotic, compelling and dynamic market in the world. HealthiosXchange is the premier capital marketplace dedicated exclusively to the industry. By aggregating 6,000 Emerging Growth healthcare companies in 37 countries, Healthios is fostering a capital markets environment.
The global healthcare industry is the most complex, chaotic, compelling and dynamic market in the world. HealthiosXchange is the premier capital marketplace dedicated exclusively to the industry. By aggregating 6,000 Emerging Growth healthcare companies in 37 countries, Healthios is fostering a capital markets environment.
The global healthcare industry is the most complex, chaotic, compelling and dynamic market in the world. HealthiosXchange is the premier capital marketplace dedicated exclusively to the industry. By aggregating 6,000 Emerging Growth healthcare companies in 37 countries, Healthios is fostering a capital markets environment.
All-at-once, the global healthcare industry is the most complex, chaotic, compelling
and dynamic market in the world.
A $3 trillion global industry, growing 16% annually, capitalizing itself $13.8 million at a time through more than 9,000 negotiated transactions in 6,000 companies into which, on average, $49 million of capital is deployed over 6.2 years, yielding a Cash-on-Cash returns of 4.1x and IRRs of 22.1% while generating 81% liquidity on invested capital through 892 Exit events, of which 87% are M&A. HealthiosXchange is the premier capital marketplace dedicated exclusively to the global healthcare industry. By aggregating 6,000 Emerging Growth healthcare companies in (37) countries together with 30,000 investors in (10) asset classes and 2,000 strategic partners representing (46) market sectors IN A SINGLE MARKET ENVIRONMENT, HealthiosXchange is fostering a capital markets environment which perfectly reflects the industry it serves. We intend to transform the manner in which capital is invested and value is realized throughout the global healthcare industry, by serving the needs of: 1. The most promising Emerging Growth Companies in the world 2. The most successful Lead Investors 3. The most active Direct Investors 4. The most competitive Strategic Partners & Buyers Healthios believes that institutional investment funds are critical to the success of the global healthcare industry, as they represent the universe of Lead investors to support the cycle of innovation, growth and value creation which is vital to the industry. At the same time, for an increasing population of alternative investors who are implementing direct investment strategies to complement their existing fund commitments, traditional fund structures are proving to be inefficient and expensive. As these investors seek to complement their 2-and-20 fund strategies with innovative investment approaches, Healthios believes there is an important opportunity to restructure global capital flows for the benefit of those investors and the global healthcare industry, itself. The urgency to transform the global healthcare capital markets and the inspiration for the HealthiosXchange is illustrated in studies published in 2012 by the Kaufmann Foundation and in 2014 by Collier Capital and Prequin. Key elements of those studies are as follows:
92% of investors expect to either Increase or Maintain their
allocations to Venture Capital and Private Equity over the long term
55% of Limited Partners with fund investments in healthcare
identified management fees as the principal motivation for a shift in investment strategies. In addition, investors cited better control of
investments, greater transparency, and an opportunity to increase
diversification.
60% of North American investors (and more than 40% of foreign
investors) would pay higher carried interest in return for lower fund management fees
77% of Limited Partners are Actively or Opportunistically
engaging in Direct Investments
24% of LPs allocate more than 10% of AUM to Direct
investment. By 2016, Direct investments will increase by 50% to 15% of AUM
86% of Limited Partners assert that Direct Investing yields either
Significantly Better or Slightly Better returns
87% of Limited Partners intend to Increase or Maintain their
Direct investment activity during the next five years
92% of Lead investors site timing, relationship and cost as the
principal objections to Direct investing
HealthiosXchange seeks to transform the manner in which capital is invested and
value is realized throughout the global healthcare industry. We intend to achieve this goal by providing Direct investors with resources necessary to: 1. Achieve Higher Returns & IRR 2. Implement a Proprietary Rules-Based Investment Strategy 3. Achieve Total Control in their Direct investment Strategy HealthiosXchange controls 100% of its transaction origination and focuses its relationships directly on the Company, itself. These two factors permit HealthiosXchange to posses extraordinary latitude over the investment process. As a result, HealthiosXchange can enhance returns & IRR for direct investors by: 1. Offering all investments on a No Fee, No Carry basis. 2. Shortening the investment period by allowing capital to be deployed directly into the Company only when it is needed 3. Accelerating liquidity by returning capital to investors immediately upon the realization of that Companys exit event Every direct investment offered through HealthiosXchange conforms to a strict Rule-Set comprised on three components:
1. Institutional Leadership: every direct investment must be led by an
institutional investor. This allows direct investors to benefit from sophisticated, like-minded partners who are performing world-class due diligence, pricing and structuring each investment, providing critical leadership and governance and deploying capital to achieve maximum economic returns. 2. Strategic Validation: a HealthiosXchange direct investment must have confirmed its investment or strategic proposition with a strategic buyer or industry expert. This engenders confidence among direct investors in the ultimate exit event 3. Established Exit Pathway: every HealthiosXchange direct investment is made in one of (46) market sectors. Within these sectors, the Company will be member of a sector watch list or Xchange Group which is overseen by the most active strategic buyers in that market sector. The Xchange Group also includes that Companys peers as well as Key Opinion Leaders and the most active institutional investors in that market sector. During the investment horizon, Xchange Groups will provide direct investors with optimal access to their portfolio and extraordinary insights into its performance. All direct investments through HealthiosXchange are initiated through an exclusive, 8-week investment evaluation process intended to provide maximum control while nurturing confidence, conviction and commitment of direct investors throughout the investment horizon. This investment process is complemented by exclusive features during the transaction. Most importantly, after the consummation of the transaction, every HealthiosXchange direct investment is supported throughout the investment horizon until the Exit is achieved. HealthiosXchange is a global capital marketplace dedicated exclusively to the healthcare industry. By aggregating IN A SINGLE MARKET ENVIRONMENT 6,000 Emerging Growth healthcare companies in (37) countries, along with 30,000 investors in (10) asset classes and 2,000 strategic partners representing (46) market sectors, HealthiosXchange provides the broadest, most direct and efficient access to the fastest growing, most dynamic markets in the world. For direct investors, in particular, HealthiosXchange can enable greater outcomes across their entire investment portfolio in three specific ways: 1. Higher Returns & IRR 2. Proprietary Rules-Based Investment Strategy 3. Total Control